[Federal Register Volume 66, Number 139 (Thursday, July 19, 2001)]
[Notices]
[Page 37657]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-18008]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army


Availability for Non-Exclusive, Exclusive, or Partially Exclusive 
Licensing of U.S. Patent Concerning Monoclonal Antibodies to 
Cholesteral and Methods

AGENCY: U.S. Army Medical Research and Materiel Command, DoD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with 37 CFR 404.6, announcement is made of the 
availability for licensing of U.S. Patent 4,885,256 entitled 
``Monoclonal Antibodies to Cholesteral and Methods'' issued December 5, 
1989. This patent has been assigned to the United States Government as 
represented by the Secretary of the Army.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, 
Frederick, Maryland 21702-5012.

FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth 
Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul 
Mele, Office of Research & Technology Assessment, (301) 619-6664. Both 
at telefax (301) 619-5034.

SUPPLEMENTARY INFORMATION: Monoclonal antibodies which demonstrate 
specific reactivity to cholesterol and methods for the detection of 
high levels of cholesterol by contacting biological specimens 
containing cholesterol with the monoclonal antibodies and measuring the 
formation of antigen-antibody complexes by immunosorbent assay.

Luz D. Ortiz,
Army Federal Register Liaison Officer.
[FR Doc. 01-18008 Filed 7-18-01; 8:45 am]
BILLING CODE 3710-08-M